Ovarian Cancer
📧 Sign up to get email alerts when something new happens for Ovarian Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-04-29Clinical Trial Update: Temozolomide and O6-benzylguanine in Treating Children With Solid Tumors [Phase 1]
Phase 1 trial of temozolomide combined with O6-benzylguanine in children with solid tumors has completed.
-
CLINICAL_TRIALS trial_result · 2015-04-29Clinical Trial Update: STELLA Trial: Transperitoneal vs. Extraperitoneal Approach for Laparoscopic Staging of Endometrial/Ovarian Cancer [NA]
The STELLA trial comparing transperitoneal versus extraperitoneal laparoscopic staging for endometrial and ovarian cancer has completed.
-
CLINICAL_TRIALS trial_result · 2015-04-21Clinical Trial Update: Prophylactic Salpingectomy for the Prevention of the Ovarian Cancer: Comparison Between Surgical Techniques [NA]
A completed clinical trial comparing surgical techniques for prophylactic salpingectomy aimed at preventing ovarian cancer in women with ute…
-
CLINICAL_TRIALS trial_result · 2015-04-16Clinical Trial Update: Paclitaxel Plus Carboplatin With or Without SCH-58500 in Treating Patients With Newly Diagnosed Stage III Ovarian or Stage III Primary Peritoneal Cancer [Phase 2, Phase 3]
Phase 2/3 trial evaluating paclitaxel plus carboplatin with or without SCH-58500 in newly diagnosed stage III ovarian cancer or stage III pr…
-
CLINICAL_TRIALS trial_result · 2015-04-10Clinical Trial Update: Whole Body Diffusion MRI for Non-invasive Lesion Detection and Therapy Follow-up: Study With Patients With Ovarian Cancer and Peritoneal Metastasis [NA]
A completed clinical trial evaluating whole-body diffusion MRI as a non-invasive tool for detecting lesions and monitoring therapy in patien…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-03-26Clinical Trial Update: Sorafenib and Bevacizumab to Treat Ovarian, Fallopian and Peritoneal Cancer [Phase 2]
Phase 2 trial evaluating sorafenib in combination with bevacizumab for ovarian, fallopian tube, and primary peritoneal cancers; study comple…
-
CLINICAL_TRIALS trial_result · 2015-03-26Clinical Trial Update: BB-10901 in Treating Patients With Relapsed or Refractory Solid Tumors [Phase 1]
This Phase 1 trial of BB-10901 in relapsed or refractory solid tumors has completed, evaluating patients with ovarian cancer, Merkel cell ca…
-
CLINICAL_TRIALS trial_result · 2015-03-23Clinical Trial Update: Vitamin D for Women at Increased Risk of Developing Ovarian, Fallopian, or Primary Peritoneal Cancer [NA]
This Northwestern University-sponsored trial evaluated Vitamin D supplementation for women at increased risk of ovarian, fallopian tube, or …
-
CLINICAL_TRIALS trial_result · 2015-03-10Clinical Trial Update: Pilot Study of Taxol, Carboplatin, and Bevacizumab in Advanced Stage Ovarian Carcinoma Patients [Phase 2]
A Phase 2 pilot study evaluating paclitaxel (Taxol), carboplatin, and bevacizumab in advanced ovarian cancer has completed.
-
CLINICAL_TRIALS trial_result · 2015-03-10Clinical Trial Update: Efficacy of NOV-002 in Combination With Carboplatin in Chemotherapy-resistant Ovarian Cancer [Phase 2]
Phase 2 trial evaluating NOV-002 with carboplatin in chemotherapy-resistant ovarian cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2015-03-10Clinical Trial Update: Safety and Efficacy Study of Glufosfamide in Ovarian Cancer [Phase 2]
Phase 2 safety and efficacy study of Glufosfamide in ovarian cancer was terminated; results were posted in 2015.
-
CLINICAL_TRIALS trial_result · 2015-03-06Clinical Trial Update: S0114 Vaccine Therapy in Treating Patients With Gastric, Prostate, or Ovarian Cancer [Phase 1]
Phase 1 clinical trial evaluating S0114 vaccine therapy in patients with brain tumors, gastric cancer, ovarian cancer, or prostate cancer ha…
-
CLINICAL_TRIALS trial_result · 2015-03-03Clinical Trial Update: A Phase II Combined Modality Protocol of Debulking Surgery With HIPEC Followed by Intraperitoneal Chemotherapy for the Treatment of Recurrent Ovarian, Primary Peritoneal & Fallopian Tube Cancers [Phase 2]
Phase II trial evaluating debulking surgery with HIPEC followed by intraperitoneal chemotherapy for recurrent ovarian, primary peritoneal, a…
-
CLINICAL_TRIALS trial_result · 2015-02-25Clinical Trial Update: AURELIA: A Study of Avastin (Bevacizumab) Added to Chemotherapy in Patients With Platinum-resistant Ovarian Cancer [Phase 3]
Phase 3 trial of Avastin added to chemotherapy for platinum-resistant ovarian cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2015-02-24Clinical Trial Update: A Study of First Line Treatment With Avastin (Bevacizumab) in Combination With Carboplatin and Weekly Paclitaxel in Patients With Ovarian Cancer [Phase 2]
Phase 2 trial of first-line ovarian cancer treatment using Avastin (bevacizumab) with carboplatin and weekly paclitaxel; results have been p…
-
CLINICAL_TRIALS trial_result · 2015-02-18Clinical Trial Update: Vinorelbine and Gemcitabine Combination In Platinum Resistant Recurrent Ovarian Cancer [Phase 2]
Phase 2 clinical trial of vinorelbine plus gemcitabine for platinum-resistant recurrent ovarian cancer has completed.
-
CLINICAL_TRIALS trial_result · 2015-02-18Clinical Trial Update: Efficacy and Safety Study of Sorafenib With Topotecan in Patients With Platinum-resistant Recurrent Ovarian Cancer [Phase 2]
This Phase 2 trial evaluates the combination of sorafenib and topotecan in patients with platinum-resistant recurrent ovarian cancer, report…
-
CLINICAL_TRIALS trial_result · 2015-02-18Clinical Trial Update: Feasibility and Clinical Activity of Initial Intraperitoneal Catumaxomab Followed by Chemotherapy in Patients With Recurrent Ovarian Cancer [Phase 2]
A Phase 2 study of intraperitoneal catumaxomab followed by chemotherapy shows feasibility and signs of clinical activity in patients with re…
-
CLINICAL_TRIALS trial_result · 2015-02-09Clinical Trial Update: Gemcitabine and Docetaxel in Treating Patients With Relapsed or Refractory Ovarian Epithelial or Peritoneal Cancer [Phase 2]
Phase 2 trial assessing gemcitabine and docetaxel in relapsed or refractory ovarian epithelial or peritoneal cancer has completed with resul…
-
CLINICAL_TRIALS trial_result · 2015-02-05Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, and Activity of Lonafarnib and Docetaxel (Study P04467AM1)(TERMINATED) [Phase 1, Phase 2]
A Phase 1/2 study evaluating safety, tolerability, and activity of lonafarnib in combination with docetaxel (Study P04467AM1) was terminated…
-
CLINICAL_TRIALS trial_result · 2015-01-26Clinical Trial Update: Study to Assess the Efficacy and Safety of a PARP Inhibitor for the Treatment of BRCA-positive Advanced Ovarian Cancer [Phase 2]
Phase 2 trial update evaluating a PARP inhibitor for BRCA-positive advanced ovarian cancer; results posted after completion.
-
CLINICAL_TRIALS trial_result · 2015-01-22Clinical Trial Update: Positron Emission Tomography/Computed Tomography (PET/CT) in Relapsed Ovarian Cancer (MK-0000-143) [Phase 1]
Phase 1 trial update evaluating PET/CT imaging with MK-0000-143 in relapsed ovarian cancer, primary peritoneal cancer, and fallopian tube ca…
-
CLINICAL_TRIALS trial_result · 2015-01-15Clinical Trial Update: LUME-Ovar 1: Nintedanib (BIBF 1120) or Placebo in Combination With Paclitaxel and Carboplatin in First Line Treatment of Ovarian Cancer [Phase 3]
Phase 3 trial assessing nintedanib added to paclitaxel and carboplatin vs placebo in first-line treatment of ovarian cancer; results were po…
-
CLINICAL_TRIALS trial_result · 2015-01-15Clinical Trial Update: A Crossover Bioequivalence Study of Intravenously Administered ATI0918 and DOXIL/CAELYX in Patients With Ovarian Cancer [Phase 1]
A Phase 1 crossover bioequivalence study comparing ATI-0918 and liposomal doxorubicin (DOXIL/CAELYX) in patients with ovarian cancer, sponso…
-
CLINICAL_TRIALS trial_result · 2015-01-13Clinical Trial Update: Phase I Study of MT110 in Lung Cancer (Adenocarcinoma and Small Cell), Gastric Cancer or Adenocarcinoma of the Gastro-Esophageal Junction, Colorectal Cancer, Breast Cancer, Hormone-Refractory Prostate Cancer, and Ovarian Cancer [Phase 1]
Phase I trial of MT110 in multiple solid tumors has completed enrollment, evaluating MT110 in lung cancer (non-small cell and small cell), g…